Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-052969
Filing Date
2019-10-10
Accepted
2019-10-10 19:12:23
Documents
2
Period of Report
2019-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8647
2 POA DOCUMENT poa.txt EX-24.3_875815 3563
  Complete submission text file 0001209191-19-052969.txt   13609
Mailing Address 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Business Address
Burow Kristina (Reporting) CIK: 0001569248 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39083 | Film No.: 191146858

Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)